» Articles » PMID: 15153614

Mesenchymal Stem Cells Can Be Differentiated into Endothelial Cells in Vitro

Overview
Journal Stem Cells
Date 2004 May 22
PMID 15153614
Citations 460
Authors
Affiliations
Soon will be listed here.
Abstract

Human bone marrow-derived mesenchymal stem cells (MSCs) have the potential to differentiate into mesenchymal tissues like osteocytes, chondrocytes, and adipocytes in vivo and in vitro. The aim of this study was to investigate the in vitro differentiation of MSCs into cells of the endothelial lineage. MSCs were generated out of mononuclear bone marrow cells from healthy donors separated by density gradient centrifugation. Cells were characterized by flow cytometry using a panel of monoclonal antibodies and were tested for their potential to differentiate along different mesenchymal lineages. Isolated MSCs were positive for the markers CD105, CD73, CD166, CD90, and CD44 and negative for typical hematopoietic and endothelial markers. They were able to differentiate into adipocytes and osteocytes after cultivation in respective media. Differentiation into endothelial-like cells was induced by cultivation of confluent cells in the presence of 2% fetal calf serum and 50 ng/ml vascular endothelial growth factor. Laser scanning cytometry analysis of the confluent cells in situ showed a strong increase of expression of endothelial-specific markers like KDR and FLT-1, and immunofluorescence analysis showed typical expression of the von Willebrand factor. The functional behavior of the differentiated cells was tested with an in vitro angiogenesis test kit where cells formed characteristic capillary-like structures. We could show the differentiation of expanded adult human MSCs into cells with phenotypic and functional features of endothelial cells. These predifferentiated cells provide new options for engineering of artificial tissues based on autologous MSCs and vascularized engineered tissues.

Citing Articles

Effect of adipose-derived mesenchymal stem cells on the viability of the transverse rectus abdominis myocutaneous flap in rats.

de Freitas A, Han S, Martin P, Ferreira L Clinics (Sao Paulo). 2025; 80:100590.

PMID: 39908748 PMC: 11847128. DOI: 10.1016/j.clinsp.2025.100590.


Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro.

Basmaeil Y, Subayyil A, Kulayb H, Kondkar A, Alrodayyan M, Khatlani T Cells. 2025; 13(24.

PMID: 39768220 PMC: 11674051. DOI: 10.3390/cells13242131.


Regenerative medicine in cardiovascular disease.

Goto T, Nakamura Y, Ito Y, Miyagawa S Regen Ther. 2024; 26:859-866.

PMID: 39430582 PMC: 11490749. DOI: 10.1016/j.reth.2024.09.004.


Role of mesenchymal stem cells in sepsis and their therapeutic potential in sepsis‑associated myopathy (Review).

Wang D, Xu L, Liu Y, Wang C, Qi S, Li Z Int J Mol Med. 2024; 54(5).

PMID: 39219272 PMC: 11374154. DOI: 10.3892/ijmm.2024.5416.


Mesenchymal Stem Cells in Myelodysplastic Syndromes and Leukaemia.

Eroz I, Kakkar P, Lazar R, El-Jawhari J Biomedicines. 2024; 12(8).

PMID: 39200142 PMC: 11351218. DOI: 10.3390/biomedicines12081677.